Judd L L, Janowsky D S, Zettner A, Huey L Y, Takahashi K I
Psychiatry Res. 1981 Jun;4(3):277-83. doi: 10.1016/0165-1781(81)90029-9.
Cortisol levels were measured before and after administration of naloxone-HCl in patients with affective disorder (n = 16) and normal control subjects (n = 8). On two consecutive days, 20 mg of naloxone-HCl or placebo was administered i.v. over 15 minutes in a double-blind crossover design. Blood samples were collected at 30, 15, and l minute(s) both before and after infusion. Cortisol rose from a mean baseline level of 14.8 microgram% to a mean peak level of 23.1 microgram% following the naloxone administration. Significant cortisol increases were found in both the 15- and 30-minute samples during the naloxone session. There were no differences between patient and normal subject samples or between diagnostic groups. A subgroup of manic patients who had responded to naloxone with a reduction of their manic behavior also had an attenuated cortisol response to naloxone. This proved to be an artifact secondary to variability in the cortisol response in these patients.
在情感障碍患者(n = 16)和正常对照受试者(n = 8)中,于静脉注射盐酸纳洛酮前后测量皮质醇水平。采用双盲交叉设计,连续两天在15分钟内静脉注射20 mg盐酸纳洛酮或安慰剂。在输注前后的30分钟、15分钟和1分钟采集血样。注射纳洛酮后,皮质醇从平均基线水平14.8微克%升至平均峰值水平23.1微克%。在注射纳洛酮期间,15分钟和30分钟的样本中均发现皮质醇显著升高。患者样本与正常受试者样本之间或诊断组之间无差异。一组对纳洛酮有反应且躁狂行为减轻的躁狂患者,其对纳洛酮的皮质醇反应也减弱。这被证明是这些患者皮质醇反应变异性导致的假象。